Lundbeck

Depression, schizophrenia, Alzheimer's, Parkinson's, epilepsy, Multiple Sclerosis, and migraines have their foundation in the Central Nervous System - our key focus areas. Lundbeck's entire R&D efforts to central nervous system (CNS) disorders.

Contact Details: Ottiliavej 9 Valby DK-2500 Denmark Tel: +45 36 30 13 11 Fax: +45 36 30 19 40 Email: information@lundbeck.com WWW: www.lundbeck.com/

Recent Publications by Lundbeck:
Monte carlo wave packet theory of dissociative double ionization. Nuclear dynamics in strong-field double ionization processes is predicted...	13th November, 2009	Lundbeck Foundation Theoretical Center for Quantum System Research,	Phys Rev Lett. 2009 Oct 30;103(18):183601. Epub 2009 Oct 27.
Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity. To date eleven human PDE (3',5'-cyclic nucleotide phosphodiesterase)...	5th November, 2009	Department of Molecular Neurobiology, H. Lundbeck A/S, Ottiliavej 9, 2500	Biochem J. 2009 Oct 12;423(3):401-9. DOI Direct Link
A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma. INTRODUCTION: Analysis of the radioactive components in plasma taken...	31st October, 2009	The PET & Cyclotron Unit and The Lundbeck Centre for Integrated Molecular	Nucl Med Biol. 2009 Nov;36(8):961-5. Epub 2009 Oct 3. DOI Direct Link
An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant. The human serotonin transporter (hSERT) has primary and allosteric binding...	27th October, 2009	Department of Biological Research, Lundbeck Research USA, Paramus, NJ	Neurosci Lett. 2009 Oct 25;462(3):207-12. Epub 2009 Jul 16. DOI Direct Link
Recent applications of intramolecular Diels-Alder reactions to natural product synthesis. This tutorial review presents some recent examples of intramolecular...	23rd October, 2009	H. Lundbeck A/S, Ottiliavej	Chem Soc Rev. 2009 Nov;38(11):2983-92. Epub 2009 Jul 29. DOI Direct Link
→View more Lundbeck research publications.

Press Releases on Lundbeck:
Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities	18th November, 2009	Reportlinker	NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Alzheimer's and Parkinson's Diseases - A Global Update of Market
Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018	17th November, 2009	Decision Resources	WALTHAM, Mass., Nov. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat
Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research	11th November, 2009	Pharma Market Research Conference	PARSIPPANY, N.J., Nov. 11 /PRNewswire/ -- Pharma market research thought leaders are discovering new ways to take advantage of the tremendous developments and opportunities in the pharmaceutical
Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018	5th November, 2009	Decision Resources	WALTHAM, Mass., Nov. 5 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion
Reportlinker Adds World Neurodegenerative Diseases Market 2009-2024	3rd November, 2009	Reportlinker	-- Rilutek. In our pipeline analyses we include emerging therapeutics such as stem cells, gene therapy and monoclonal antibodies, among other prominent developments. Detailed analysis of the

BioNews Results for Lundbeck:
Institute for Quality and Efficiency in Health Care: Benefit of memantine in the treatment of Alzheimer's disease not proven	NewsRX:  Nov 14 2009 5:14AM Matching: lundbeck
Breast Cancer May Be Gone, But Pain Lingers	Springfield News Sun:  Nov 12 2009 5:54PM Matching: lundbeck
Breast Cancer May Be Gone, But Pain Lingers	MedicineNet.com:  Nov 12 2009 10:50AM Matching: lundbeck
Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research	Earthtimes.org:  Nov 12 2009 7:17AM Matching: lundbeck
Breast Cancer May Be Gone, But Pain Lingers (HealthDay)	Yahoo! News:  Nov 11 2009 9:57PM Matching: lundbeck
Promote your company here: BioNewsCast - Press Release Distribution	→View more Lundbeck news.

Lundbeck Clinical Trials:
Long-term Safety Study of Lu AA21004 in Patients With Major Depressive Disorder

Lundbeck Patents:
US Patent No.	Title
7041461	Methods of identifying agonists and antagonists of mammalian NPFF receptor
7189720	Selective NPY (Y5) antagonists
7199135	Substituted alkyl amido piperidines
7220775	Compound useful for the treatment of neuropathic pain
7223765	4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
→View more Lundbeck patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 80 individuals from Lundbeck using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 418 times since April 2007, the link to the organisation's website has been followed 64 times

Recent Search Terms used to find this page: lundbeck august 2009 | lunbeck labs paramus | Lundbeck department of biology | lundbeck biologicals | lundbeck neurobiology email | .

Search for more companies in Valby

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Lundbeck